Genome-wide analysis of DNA methylation and cigarette smoking in a Chinese population

Environmental Health Perspectives

Volumn 124, Issue 7, 2016, Pages 966-973

  Zhu, Xiaoyan ^a   Li, Jun ^a,b   Deng, Siyun ^a   Yu, Kuai ^a   Liu, Xuezhen ^a   Deng, Qifei ^a   Sun, Huizhen ^a   Zhang, Xiaomin ^a   He, Meian ^a   Guo, Huan ^a   Chen, Weihong ^a   Yuan, Jing ^a   Zhang, Bing ^a   Kuang, Dan ^a   He, Xiaosheng ^a   Bai, Yansen ^a   Han, Xu ^a   Liu, Bing ^a   Li, Xiaoliang ^a   Yang, Liangle ^a   Jiang, Haijing ^a   Zhang, Yizhi ^a   Hu, Jie ^a   Cheng, Longxian ^a   Luo, Xiaoting ^c   Mei, Wenhua ^c   Zhou, Zhiming ^d   Sun, Shunchang ^d   Zhang, Liyun ^e   Liu, Chuanyao ^a   Guo, Yanjun ^a   Zhang, Zhihong ^a   Hu, Frank B ^b,f   Liang, Liming ^b   Wu, Tangchun ^a   more..

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c ZHUHAI PEOPLE S HOSPITAL ZHUHAI HOSPITAL AFFILIATED WITH JINAN UNIVERSITY   (China)

^d Water Authority of Bao'an District   (China)

^e Wuhan Central Hospital   (China)

^f HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 NAPHTHOL; ANKYRIN; CREATININE; INTERLEUKIN 6 RECEPTOR; PEPTIDES AND PROTEINS; POLYCYCLIC AROMATIC HYDROCARBON DERIVATIVE; PROTEIN CDH23; PROTEIN CEP135; TRANSCRIPTION FACTOR RUNX3; UNCLASSIFIED DRUG; 2-NAPHTHOL; CYTIDYLYL-3'-5'-GUANOSINE; DINUCLEOSIDE PHOSPHATE; NAPHTHOL DERIVATIVE;

ACUTE CORONARY SYNDROME; ADULT; ARTICLE; CHINESE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENETIC ASSOCIATION; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOKING; URINALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; EPIDEMIOLOGY; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; RISK FACTOR; URINE;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; DINUCLEOSIDE PHOSPHATES; DNA METHYLATION; FEMALE; GENE EXPRESSION; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; NAPHTHOLS; RISK FACTORS; SMOKING;

EID: 84977140503     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1509834     Document Type: Article

References (63)

1. Agarwal SK. 2014. Integrins and cadherins as therapeutic targets in fibrosis. Front Pharmacol 5:131, doi:10.3389/fphar.2014.00131.
2. Aryee MJ, Jaffe AE, Corrada-Bravo H, Ladd-Acosta C, Feinberg AP, Hansen KD, et al. 2014. Minfi: a flexible and comprehensive Bioconductor package for the analysis of Infinium DNA methylation microarrays. Bioinformatics 30:1363-1369.
3. Barr DB, Bishop A, Needham LL. 2007. Concentrations of xenobiotic chemicals in the maternal-fetal unit. Reprod Toxicol 23:260-266.
4. Besingi W, Johansson A. 2014. Smoke-related DNA methylation changes in the etiology of human disease. Hum Mol Genet 23:2290-2297.
5. Binai NA, Carra G, Löwer J, Löwer R, Wessler S. 2013. Differential gene expression in ERα-positive and ERα-negative breast cancer cells upon leptin stimulation. Endocrine 44:496-503.
6. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, et al. 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625-631.
7. Breitling LP, Salzmann K, Rothenbacher D, Burwinkel B, Brenner H. 2012. Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J 33:2841-2848.
8. Breitling LP, Yang R, Korn B, Burwinkel B, Brenner H. 2011. Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet 88:450-457.
9. CDC (Centers for Disease Control and Prevention). 2010. 2010 Surgeon General’s Report—How Tobacco Smoke Causes Disease: The Biology and Behavioral Basis for Smoking-Attributable Disease. Atlanta, GA:CDC. Available: http://www.cdc.gov/tobacco/data_statistics/sgr/2010/ [accessed 13 September 2014].
10. Cunningham TJ, Ford ES, Rolle IV, Wheaton AG, Croft JB. 2014. Associations of self-reported ciga-rette smoking with chronic obstructive pulmonary disease and co-morbid chronic conditions in the United States. COPD 12:276-286, doi:10.3109/15412555.2014.949001.
11. Deng Q, Huang S, Zhang X, Zhang W, Feng J, Wang T, et al. 2014. Plasma microRNA expression and micronuclei frequency in workers exposed to polycyclic aromatic hydrocarbons. Environ Health Perspect 122:719-725, doi:10.1289/ehp.1307080.
12. Ding YS, Trommel JS, Yan XJ, Ashley D, Watson CH. 2005. Determination of 14 polycyclic aromatic hydrocarbons in mainstream smoke from domestic cigarettes. Environ Sci Technol 39:471-478.
13. Dogan MV, Shields B, Cutrona C, Gao L, Gibbons FX, Simons R, et al. 2014. The effect of smoking on DNA methylation of peripheral blood mononuclear cells from African American women. BMC Genomics 15:151, doi:10.1186/1471-2164-15-151.
14. Dunning MJ, Smith ML, Ritchie ME, Tavaré S. 2007. beadarray: R classes and methods for Illumina bead-based data. Bioinformatics 23:2183-2184.
15. Elliott HR, Tillin T, McArdle WL, Ho K, Duggirala A, Frayling TM, et al. 2014. Differences in smoking associated DNA methylation patterns in South Asians and Europeans. Clin Epigenetics 6:4, doi:10.1186/1868-7083-6-4.
16. Ezzati M, Lopez AD. 2003. Estimates of global mortality attributable to smoking in 2000. Lancet 362:847-852.
17. Feil R, Fraga MF. 2012. Epigenetics and the environment: emerging patterns and implications. Nat Rev Genet 13:97-109.
18. Ferreira RC, Freitag DF, Cutler AJ, Howson JM, Rainbow DB, Smyth DJ, et al. 2013. Functional IL6R 358Ala allele impairs classical IL-6 receptor signaling and influences risk of diverse inflammatory diseases. PLoS Genet 9:e1003444, doi:10.1371/journal.pgen.1003444.
19. Frostegård J. 2013. Immunity, atherosclerosis and cardiovascular disease. BMC Med 11:117, doi:10.1186/1741-7015-11-117.
20. Furniss CS, Marsit CJ, Houseman EA, Eddy K, Kelsey KT. 2008. Line region hypomethylation is associated with lifestyle and differs by human papillomavirus status in head and neck squamous cell carcinomas. Cancer Epidemiol Biomarkers Prev 17:966-971.
21. Gandini S, Botteri E, Iodice S, Boniol M, Lowenfels AB, Maisonneuve P, et al. 2008. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 122:155-164.
22. Gu D, Kelly TN, Wu X, Chen J, Samet JM, Huang JF, et al. 2009. Mortality attributable to smoking in China. N Engl J Med 360:150-159.
23. Guida F, Sandanger TM, Castagné R, Campanella G, Polidoro S, Palli D, et al. 2015. Dynamics of smoking-induced genome-wide methylation changes with time since smoking cessation. Hum Mol Genet 24:2349-2359.
24. Harlid S, Xu Z, Panduri V, Sandler DP, Taylor JA. 2014. CpG sites associated with cigarette smoking: analysis of epigenome-wide data from the Sister Study. Environ Health Perspect 122:673-678, doi:10.1289/ehp.1307480.
25. IARC (International Agency for Research on Cancer). 2004. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum 83.
26. Jacob P III, Abu Raddaha AH, Dempsey D, Havel C, Peng M, Yu L, et al. 2013. Comparison of nicotine and carcinogen exposure with water pipe and ciga-rette smoking. Cancer Epidemiol Biomarkers Prev 22:765-772.
27. Jaffe AE, Irizarry RA. 2014. Accounting for cellular heterogeneity is critical in epigenome-wide asso-ciation studies. Genome Biol 15:R31, doi:10.1186/gb-2014-15-2-r31.
28. Joubert BR, Håberg SE, Nilsen RM, Wang X, Vollset SE, Murphy SK, et al. 2012. 450K epigenome-wide scan identifies differential DNA methylation in newborns related to maternal smoking during pregnancy. Environ Health Perspect 120:1425-1431, doi:10.1289/ehp.1205412.
29. Kim K, Lee S, Chang J, Rhee K. 2008. A novel function of CEP135 as a platform protein of C-NAP1 for its centriolar localization. Exp Cell Res 314:3692-3700.
30. Lee KW, Pausova Z. 2013. Cigarette smoking and DNA methylation. Front Genet 4:132, doi:10.3389/fgene.2013.00132.
31. Lee Y, Gustafsson AB. 2009. Role of apoptosis in cardiovascular disease. Apoptosis 14:536-548.
32. Leek JT, Johnson WE, Parker HS, Jaffe AE, Storey JD. 2012. The sva package for removing batch effects and other unwanted variation in high-throughput experiments. Bioinformatics 28:882-883.
33. Li X, Feng Y, Deng H, Zhang W, Kuang D, Deng Q, et al. 2012. The dose-response decrease in heart rate variability: any association with the metabolites of polycyclic aromatic hydrocarbons in coke oven workers? PLoS One 7:e44562, doi:10.1371/journal.pone.0044562.
34. Lim SP, Wong NC, Suetani RJ, Ho K, Ng JL, Neilsen PM, et al. 2012. Specific-site methylation of tumour suppressor ANKRD11 in breast cancer. Eur J Cancer 48:3300-3309.
35. Lotem J, Levanon D, Negreanu V, Bauer O, Hantisteanu S, Dicken J, et al. 2015. Runx3 at the interface of immunity, inflammation and cancer. Biochim Biophys Acta 1855:131-143.
36. Markunas CA, Xu Z, Harlid S, Wade PA, Lie RT, Taylor JA, et al. 2014. Identification of DNA methyla-tion changes in newborns related to maternal smoking during pregnancy. Environ Health Perspect 122:1147-1153, doi:10.1289/ehp.1307892.
37. Mathers CD, Loncar D. 2006. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442, doi:10.1371/journal.pmed.0030442.
38. Neilsen PM, Cheney KM, Li CW, Chen JD, Cawrse JE, Schulz RB, et al. 2008. Identification of ANKRD11 as a p53 coactivator. J Cell Sci 121(pt 21):3541-3552.
39. Nigg EA. 2002. Centrosome aberrations: cause or consequence of cancer progression? Nat Rev Cancer 2:815-825.
40. Ninio E, Tregouet D, Carrier JL, Stengel D, Bickel C, Perret C, et al. 2004. Platelet-activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease. Hum Mol Genet 13:1341-1351.
41. Ohgane J, Yagi S, Shiota K. 2008. Epigenetics: the DNA methylation profile of tissue-dependent and differ-entially methylated regions in cells. Placenta 29 (suppl A):S29-S35.
42. Philibert RA, Beach SR, Gunter TD, Brody GH, Madan A, Gerrard M. 2010. The effect of smoking on MAOA promoter methylation in DNA prepared from lymphoblasts and whole blood. Am J Med Genet B Neuropsychiatr Genet 153B:619-628.
43. Philibert RA, Beach SR, Lei MK, Brody GH. 2013. Changes in DNA methylation at the aryl hydrocarbon receptor repressor may be a new biomarker for smoking. Clin Epigenetics 5:19, doi:10.1186/1868-7083-5-19.
44. Pidsley R, Wong CCY, Volta M, Lunnon K, Mill J, Schalkwyk LC. 2013. A data-driven approach to preprocessing Illumina 450k methylation array data. BMC Genomics 14:293, doi:10.1186/1471-2164-14-293.
45. Qiao D, Seidler FJ, Violin JD, Slotkin TA. 2003. Nicotine is a developmental neurotoxicant and neuro-protectant: stage-selective inhibition of DNA synthesis coincident with shielding from effects of chlorpyrifos. Brain Res Dev Brain Res 147:183-190.
46. R Core Team. 2014. R: A Language and Environment for Statistical Computing. Vienna, Austria:R Foundation for Statistical Computing. Available: http://www.R-project.org/ [accessed 5 July 2014].
47. Rea TD, Heckbert SR, Kaplan RC, Smith NL, Lemaitre RN, Psaty BM. 2002. Smoking status and risk for recurrent coronary events after myocardial infarction. Ann Intern Med 137:494-500.
48. Reinius LE, Acevedo N, Joerink M, Pershagen G, Dahlén SE, Greco D, et al. 2012. Differential DNA methylation in purified human blood cells: implications for cell lineage and studies on disease susceptibility. PLoS One 7:e41361, doi:10.1371/journal.pone.0041361.
49. Reynolds P, Goldberg D, Hurley S, Nelson DO, Largent J, Henderson KD, et al. 2009. Passive smoking and risk of breast cancer in the California Teachers Study. Cancer Epidemiol Biomarkers Prev 18:3389-3398.
50. Rodgman A, Smith CJ, Perfetti TA. 2000. The composition of cigarette smoke: a retrospective, with emphasis on polycyclic components. Hum Exp Toxicol 19:573-595.
51. Rusan NM, Peifer M. 2007. A role for a novel centrosome cycle in asymmetric cell division. J Cell Biol 177:13-20.
52. Schadt EE. 2009. Molecular networks as sensors and drivers of common human diseases. Nature 461:218-223.
53. Shenker NS, Polidoro S, van Veldhoven K, Sacerdote C, Ricceri F, Birrell MA, et al. 2013. Epigenome-wide association study in the European Prospective Investigation into Cancer and Nutrition (EPIC-Turin) identifies novel genetic loci associated with smoking. Hum Mol Genet 22:843-851.
54. Smith IM, Mydlarz WK, Mithani SK, Califano JA. 2007. DNA global hypomethylation in squamous cell head and neck cancer associated with smoking, alcohol consumption and stage. Int J Cancer 121:1724-1728.
55. Song Y, Hou J, Huang X, Zhang X, Tan A, Rong Y, et al. 2014. The Wuhan-Zhuhai (WHZH) cohort study of environmental air particulate matter and the pathogenesis of cardiopulmonary diseases: study design, methods and baseline characteristics of the cohort. BMC Public Health 14:994, doi:10.1186/1471-2458-14-994.
56. Sosnowski R, Przewoźniak K. 2015. The role of the urologist in smoking cessation: why is it important? Urol Oncol 33:30-39.
57. Sun YV, Smith AK, Conneely KN, Chang Q, Li W, Lazarus A, et al. 2013. Epigenomic association analysis identifies smoking-related DNA methylation sites in African Americans. Hum Genet 132:1027-1037.
58. Valeri L, Vanderweele TJ. 2013. Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 18:137-150.
59. Vogt Isaksen C. 2004. Maternal smoking, intrauterine growth restriction, and placental apoptosis. Pediatr Dev Pathol 7:433-442.
60. von Hundelshausen P, Weber C. 2007. Platelets as immune cells: bridging inflammation and cardio-vascular disease. Circ Res 100:27-40.
61. WHO (World Health Organization). 2014. Tobacco. Fact Sheet No. 339. Available: http://www.who. int/mediacentre/factsheets/fs339/en/ [accessed 26 August 2014].
62. Zeilinger S, Kühnel B, Klopp N, Baurecht H, Kleinschmidt A, Gieger C, et al. 2013. Tobacco smoking leads to extensive genome-wide changes in DNA methylation. PLoS One 8:e63812, doi:10.1371/journal.pone.0063812.
63. Zhang Y, Yang R, Burwinkel B, Breitling LP, Holleczek B, Schöttker B, et al. 2014. F2RL3 methylation in blood DNA is a strong predictor of mortality. Int J Epidemiol 43:1215-1225.